B cells in chronic graft-versus-host disease

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Chronic graft-versus-host disease (cGVHD) is a frequent complication following allogeneic hematopoietic stem cell transplantation.
• While acute graft-versus-host disease is T cell-mediated, cGVHD involves a more complex immune pathology, with donor B cells playing a significant role.

Purpose of the Study:

• To review the mechanisms of B cell activation and loss of tolerance in cGVHD.
• To discuss novel B cell-directed agents identified in preclinical models for cGVHD prevention and treatment.
• To summarize clinical trial results of existing B cell-directed therapies for cGVHD.

Main Methods:

• Review of recent laboratory studies on B cell involvement in cGVHD.
• Analysis of preclinical models investigating novel B cell-directed agents.
• Evaluation of clinical trial data for B cell-directed therapies in cGVHD patients.

Main Results:

• Mechanistic studies highlight persistent B cell activation and loss of B cell tolerance in cGVHD.
• Preclinical models suggest novel B cell-directed agents may be effective for cGVHD.
• Early clinical studies indicate potential efficacy of B cell-directed therapies for cGVHD.

Conclusions:

• Understanding B cell mechanisms in cGVHD is advancing therapeutic strategies.
• B cell-directed therapies represent a promising approach for cGVHD prevention and treatment.
• Further clinical trials are warranted to evaluate new B cell-directed therapies for cGVHD.